Lupus nephritis risk factors and biomarkers: An update

Y Renaudineau, W Brooks, J Belliere - International Journal of Molecular …, 2023 - mdpi.com
Lupus nephritis (LN) represents the most severe organ manifestation of systemic lupus
erythematosus (SLE) in terms of morbidity and mortality. To reduce these risks, tremendous …

Lupus nephritis biomarkers: a critical review

FK Alduraibi, GC Tsokos - International Journal of Molecular Sciences, 2024 - mdpi.com
Lupus nephritis (LN), a major complication in individuals diagnosed with systemic lupus
erythematosus, substantially increases morbidity and mortality. Despite marked …

Lupus nephritis in children: novel perspectives

M Pennesi, S Benvenuto - Medicina, 2023 - mdpi.com
Childhood-onset systemic lupus erythematosus is an inflammatory and autoimmune
condition characterized by heterogeneous multisystem involvement and a chronic course …

The role of bilirubin as a biomarker of rheumatic diseases: a systematic review and meta-analysis

A Zinellu, AA Mangoni - Frontiers in Immunology, 2024 - frontiersin.org
The identification of novel, yet easily measurable biomarkers of inflammation and oxidative
stress might assist in the diagnosis and management of patients with rheumatic diseases …

Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review

L Catanese, H Rupprecht, TB Huber… - International Journal of …, 2024 - mdpi.com
Effective management of glomerular kidney disease, one of the main categories of chronic
kidney disease (CKD), requires accurate diagnosis, prognosis of progression, assessment …

The diagnostic role of the systemic inflammation index in patients with immunological diseases: a systematic review and meta-analysis

AA Mangoni, A Zinellu - Clinical and Experimental Medicine, 2024 - Springer
The identification of novel, easily measurable biomarkers of inflammation might enhance the
diagnosis and management of immunological diseases (IDs). We conducted a systematic …

[HTML][HTML] Association of autoantibodies with the IFN signature and NETosis in patients with Systemic Lupus Erythematosus

ED Kaan, TE Brunekreef, J Drylewicz… - Journal of Translational …, 2024 - Elsevier
Objective Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by
a variety of disease symptoms and an unpredictable clinical course. To improve treatment …

Classifying systemic lupus erythematosus using laboratory items alone: a preliminary study

L Zhang, J Ma, D Yan, Z Liu, L Xue - Clinical Rheumatology, 2024 - Springer
Objectives To explore the performance of laboratory items alone in systemic lupus
erythematosus (SLE) classification. Methods Our cohort consisted of 352 and 385 (control) …

Niveles de expresión génica relativa del gen codificante de la proteína quimioatractante de monocitos-1 (MCP-1) como biomarcador urinario en nefropatía lúpica

EC Alarcón, M de la Cruz Mendoza, RP Vargas… - Revista Colombiana de …, 2024 - Elsevier
Introducción La nefropatía lúpica (NL) es un proceso inflamatorio crónico caracterizado por
la activación de células T y niveles elevados de diversas citocinas, como la MCP-1 a nivel …

Anti-C1q como Marcador de Nefritis Lúpica

E Kokuina, TOT Barbeito, WLF San Juan… - Revista Cubana de …, 2023 - revmedicina.sld.cu
Introducción: Los autoanticuerpos anti-C1q han sido propuestos como un marcador útil en
el lupus eritematoso sistémico por su asociación con la nefritis lúpica. Objetivo: Determinar …